The diabetic patient with hypertension

Area of Science:

• Nephrology
• Cardiology
• Endocrinology

Background:

• Hypertension and diabetes frequently coexist, increasing cardiovascular and renal risks.
• Diabetic renal disease, detectable by microalbuminuria, is a common complication.
• Ambulatory blood pressure monitoring can reveal nocturnal dipping loss, missed by standard measures.

Purpose of the Study:

• To review the management of hypertension in patients with diabetes.
• To highlight the importance of aggressive blood pressure control in preserving renal function.
• To discuss the cardiovascular and metabolic effects of various antihypertensive drugs.

Main Methods:

• Review of current literature on hypertension and diabetes management.
• Analysis of cardiovascular events and renal function in relation to blood pressure.
• Evaluation of antihypertensive drug classes and their impact on metabolic parameters and left ventricular hypertrophy.

Main Results:

• Aggressive hypertension treatment is vital for slowing glomerular filtration rate decline.
• No 'J'-shaped curve observed for blood pressure and cardiovascular events in diabetics, supporting lower targets.
• Angiotensin-converting enzyme inhibitors offer renoprotective benefits.
• Non-dihydropyridine calcium antagonists are preferred over dihydropyridines due to potential proteinuria augmentation.
• Alpha-adrenergic antagonists may improve lipid profiles; beta-blockers and thiazide diuretics can negatively impact glycemic and lipid profiles.

Conclusions:

• Effective hypertension management is essential for reducing morbidity and mortality in diabetic patients.
• Drug selection should consider effects on renal function, cardiovascular health, and metabolic parameters.
• ACE inhibitors and non-dihydropyridine calcium antagonists are favorable choices, while beta-blockers and thiazides require careful consideration.